Photo taken from Jay Bradner/LinkedIn
Dec 20, 2023, 18:43
Jay Bradner: I am overjoyed by the opportunity to create and develop therapeutic solutions for patients
Jay Bradner, Executive Vice President of R&D, and Chief Scientific Officer at Amgen shared on LinkedIn:
“Bob Bradway today announced that I have joined his leadership team as Executive Vice President of R&D, and Chief Scientific Officer. I am overjoyed by the opportunity to create and develop therapeutic solutions for patients with serious illnesses and to work alongside such wonderful people. Here are some additional reflections.”
For details click here.
Source: Jay Bradner/LinkedIn
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 23, 2025, 08:09
Apr 23, 2025, 07:49
Apr 23, 2025, 07:21
Apr 23, 2025, 06:49
Apr 23, 2025, 06:34
Apr 23, 2025, 06:24